International Flavors & Fragrances(US:IFF)2025-08-06 13:00Financial Performance - Q2 2025 - Revenue reached $2764 million, a decrease of 4% compared to 2024, but increased by 3% on a comparable currency neutral basis[26] - Adjusted Operating EBITDA was $552 million, a decrease of 6% compared to 2024, but increased by 6% on a comparable currency neutral basis[26] - Adjusted Operating EBITDA Margin was 200%, a decrease of 40 bps, but increased by 50 bps on a comparable currency neutral basis[26] - Food Ingredients adjusted EBITDA margin improved by 170 bps to 146%[26] Segment Performance - Q2 2025 (Comparable Currency Neutral) - Taste segment sales increased by 6% to $631 million, with adjusted operating EBITDA increasing by 3% to $125 million[28] - Food Ingredients segment sales increased by 1% to $850 million, with adjusted operating EBITDA increasing by 21% to $124 million[28] - Health & Biosciences segment sales increased by 4% to $577 million, with adjusted operating EBITDA increasing by 3% to $151 million[28] - Scent segment sales increased by 1% to $603 million, with adjusted operating EBITDA decreasing by 2% to $130 million[28] - Pharma Solutions segment sales increased by 21% to $103 million, with adjusted operating EBITDA increasing by 5% to $22 million[28] Cash Flow & Capital Allocation - Cash flow from operations totaled $368 million[30] - Capital expenditures year-to-date were $274 million, approximately 5% of sales[30] - Free cash flow was $94 million[30] - Net debt to credit adjusted EBITDA was 25x, with gross debt totaling $6213 million and cash and cash equivalents finishing at $816 million[30] - Announced a $500 million share repurchase authorization[25] FY 2025 Outlook - Revenue is projected to be between $106 billion and $109 billion, with comparable currency neutral growth of 1% to 4%[36] - Adjusted operating EBITDA is projected to be between $2 billion and $215 billion, with comparable currency neutral growth of 5% to 10%[36]